期刊
BRAIN RESEARCH BULLETIN
卷 164, 期 -, 页码 75-82出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2020.08.013
关键词
Central nervous system injuries; FTY720; Apoptosis; Oxidative stress; Autophagy; Downstream molecules
资金
- National Natural Science Foundation of China, China [81672503, 81702484]
Central nervous system (CNS) injuries, such as traumatic brain injury (TBI), subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH), are important causes of disability and death worldwide. FTY720, a structural sphingosine analog and sphingosine-1-phosphate receptor (S1PR) modulator, is currently used in the treatment of relapsing-remitting multiple sclerosis (RRMS). However, recent in vivo and in vitro studies suggest that FTY720 plays a key role in many neurological diseases, especially in CNS injuries. In addition, FTY720 is under clinical trial for the treatment of acute stroke and ICH. FTY720 could exert anti-apoptosis, anti-inflammation and anti-oxidative stress effects in CNS injuries through different molecules and pathways such as sphingosine-1-phosphate receptor (S1PR), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B (PI3K/AKT), protein phosphatase 2A (PP2A) and P2 x 7 receptor (P2 x 7R). Thus, FTY720 shows great promise for the treatment of CNS injuries. This review covers a brief introduction about the relationship between FTY270 and CNS injuries, and an updated overview of downstream molecules of FTY720 in CNS injuries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据